XTL Biopharmaceuticals Ltd. (XTLB) rose 7.12% or 0.12 to $1.86. It is approximately 19011 shares traded, which is 289.4% compare to the average total volume 6569. The market cap of XTLB is $9.56 million. The year to date change is -28.83%. The 52 week price range is from $1.62 to $4.14. Price of XTLB have changed -3.53% during last week. It have changed -3.53% over last month, -29.98% over last 3 months, -32.17% over last 6 months and -31.91% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for XTLB is 2.00. It is 7.53% above current price. The 200-day Moving Averages for XTLB is 2.50. It is 34.41% above current price. The 52-week High is 4.14. It is 122.58% from the current price. The 52-week Low is 1.62. It is -12.90% from current price.
Some people may be interesting about short interest ratio of a stock. The short interest ratio of XTLB is 9.44 on 2018-02-28. Short % to float is 1.11%. There are some statistics of XTLB. It is has market cap $9.56 million. The share outstanding is 5.14 million. The average volume is 6569. The percent of top 15 Institution holding is 3.50%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of XTLB is -23.37%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of XTLB is -15.58%.